Rapibloc 300 mg
As listed in the register: Rapibloc 300 mg, Pulver zur Herstellung einer Infusionslösung
300 mg ·
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Landiololum
- Made by
- OrPha Swiss GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Hoch selektiver Beta-1-Adrenorezeptor-Antagonist
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | OrPha Swiss GmbH |
|---|---|
| Active substance | Landiololum |
| Used in | Heart, blood pressure and circulation |
| Strength | 300 mg |
| Classification | C07AB14 · Heart, blood pressure and circulation |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Rapibloc 300 mg, Pulver zur Herstellung einer Infusionslösung |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 68611 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.